The 11th International Symposium on Targeted Alpha Therapy (TAT11) will be held in Ottawa, Canada April 1-5th 2019. TAT11 is jointly organized by Canadian Nuclear Laboratories and TRIUMF. The 11th International Symposium on Targeted Alpha Therapy continues a successful series of international symposia on this topic initiated by the Joint Research Centre of the European Commission, including meetings in Karlsruhe (1997, 2000), Heidelberg (2002), Düsseldorf (2004), Aachen (2007), Toronto (2009), Berlin (2011), Oak Ridge (2013), Warsaw (2015) and Kanazawa (2017).
Introducing: The First Ever TAT Clinical Day!
With Targeted Alpha Therapy treatments beginning to hit the market, the clinical perspective has become an essential part of the TAT conversation. That's why TAT 11 is proud to announce the first ever TAT Clinical Day, including an all-day clinical track featuring leading practitioners in the field. Learn firsthand about the challenges and opportunities presented by Targeted Alpha Therapies from the world's top clinical experts.
The Clinical Committee is accepting the submission of abstracts of oral and poster presentations for the Clinical Day. Click here for details